Related Experiment Videos
Prophylaxis with trimethoprim-sulfamethoxazole in abdominal, pelvic, and prostatic surgery
Abstract:
The literature on use of trimethoprim-sulfamethoxazole (TMP-SMZ) for prophylaxis in abdominal, pelvic, and prostatic surgery is meager. There is some evidence that TMP-SMZ may be effective prophylactically in biliary surgery (in patients with functioning gall bladders). Further study is needed to clarify the mixed results seen in prostatic and pelvic surgery. An evaluation was made of the effectiveness of TMP-SMZ in the prevention of endomyometritis following cesarean section in 206 women who were comparable in terms of risk factors. Among patients given a placebo, a total of 44 infections (42%) occurred, whereas among those given TMP-SMZ prophylaxis, 22 infections (22%) occurred, a statistically significant difference (P = .037, chi 2). The rate of endomyometritis among placebo recipients was 33%, as contrasted with one of 19% in those given TMP-SMZ (P = .02, chi 2). Prophylactic treatment resulted in lower rates of endomyometritis in both high- and low-risk women, but the results reached statistical significance only among high-risk patients. In essence, prophylaxis changed high-risk patients into low-risk patients.
Insights
Trimethoprim-sulfamethoxazole (TMP-SMZ) effectively prevents endomyometritis after cesarean sections. This antibiotic prophylaxis significantly reduced infection rates, particularly in high-risk patients.
Area of Science:
- Obstetrics and Gynecology
- Infectious Disease Prevention
- Surgical Prophylaxis
Background:
- Limited literature exists on antibiotic prophylaxis for abdominal, pelvic, and prostatic surgeries.
- Trimethoprim-sulfamethoxazole (TMP-SMZ) shows potential efficacy in biliary surgery.
- Further research is needed for prostatic and pelvic surgery prophylaxis.
Purpose of the Study:
- To evaluate the effectiveness of TMP-SMZ in preventing endomyometritis following cesarean section.
- To assess TMP-SMZ prophylaxis in both high- and low-risk patient groups.
Main Methods:
- A study involving 206 women undergoing cesarean section, comparable in risk factors.
- Randomized comparison of TMP-SMZ prophylaxis versus placebo.
- Statistical analysis using chi-squared tests to compare infection rates.
Main Results:
- TMP-SMZ prophylaxis significantly reduced overall infection rates from 42% (placebo) to 22% (P = .037).
- Endomyometritis rates decreased from 33% in the placebo group to 19% in the TMP-SMZ group (P = .02).
- Prophylaxis demonstrated a significant benefit in high-risk patients, effectively lowering their risk profile.
Conclusions:
- TMP-SMZ is an effective prophylactic agent against endomyometritis in cesarean section patients.
- Prophylactic TMP-SMZ significantly lowers infection rates, especially in high-risk individuals.
- The findings support the use of TMP-SMZ for preventing postpartum infections after cesarean delivery.